Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05303779Completed
Randomised, open-label trial (2 arms), sponsored by Cairo University. Primary endpoint: Changing in eye control at 12 weeks. Started Mar 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05303779.